JP2024532677A5 - - Google Patents
Info
- Publication number
- JP2024532677A5 JP2024532677A5 JP2024505333A JP2024505333A JP2024532677A5 JP 2024532677 A5 JP2024532677 A5 JP 2024532677A5 JP 2024505333 A JP2024505333 A JP 2024505333A JP 2024505333 A JP2024505333 A JP 2024505333A JP 2024532677 A5 JP2024532677 A5 JP 2024532677A5
- Authority
- JP
- Japan
- Prior art keywords
- moiety
- oligo
- auristatin
- cancer
- berotecan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL285208 | 2021-07-28 | ||
| IL28520821 | 2021-07-28 | ||
| PCT/IL2022/050782 WO2023007481A1 (en) | 2021-07-28 | 2022-07-20 | Water soluble prodrug, conjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532677A JP2024532677A (ja) | 2024-09-10 |
| JP2024532677A5 true JP2024532677A5 (cg-RX-API-DMAC10.html) | 2025-07-23 |
Family
ID=85086377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505333A Pending JP2024532677A (ja) | 2021-07-28 | 2022-07-20 | 水溶性プロドラッグ、複合体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4377292A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024532677A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117999254A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022318483A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3226393A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL310354A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023007481A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4566631A1 (en) * | 2023-12-06 | 2025-06-11 | Heidelberg Pharma Research GmbH | New antibody drug conjugate as well as methods of production and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017531620A (ja) * | 2014-09-12 | 2017-10-26 | ジェネンテック, インコーポレイテッド | システイン操作抗体及びコンジュゲート |
| KR102710962B1 (ko) * | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| AU2019365238A1 (en) * | 2018-10-24 | 2021-05-13 | F. Hoffmann-La Roche Ag | Conjugated chemical inducers of degradation and methods of use |
| CN113613679A (zh) * | 2019-03-19 | 2021-11-05 | 保罗·谢勒学院 | 基于甘氨酸的接头的转谷氨酰胺酶缀合方法 |
-
2022
- 2022-07-20 AU AU2022318483A patent/AU2022318483A1/en active Pending
- 2022-07-20 CN CN202280053086.7A patent/CN117999254A/zh active Pending
- 2022-07-20 IL IL310354A patent/IL310354A/en unknown
- 2022-07-20 WO PCT/IL2022/050782 patent/WO2023007481A1/en not_active Ceased
- 2022-07-20 EP EP22848817.7A patent/EP4377292A4/en active Pending
- 2022-07-20 CA CA3226393A patent/CA3226393A1/en active Pending
- 2022-07-20 JP JP2024505333A patent/JP2024532677A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7403507B2 (ja) | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート | |
| CN113827736B (zh) | 一种带有高稳定性亲水连接单元的喜树碱类药物及其偶联物 | |
| JP2022530524A5 (cg-RX-API-DMAC10.html) | ||
| JP2025106317A (ja) | 生物活性分子コンジュゲート、その調製法及び使用 | |
| JP6871858B2 (ja) | 抗体薬物コンジュゲート | |
| BR112021004656A2 (pt) | conjugado fármaco-ligante de análogo exatecano, método para preparar o mesmo e aplicação do mesmo | |
| JP6957629B2 (ja) | 非線状自壊性リンカーおよびそのコンジュゲート | |
| WO2024227439A1 (zh) | 具有靶向作用的偶联物及其制备方法和用途 | |
| WO2024235136A9 (zh) | 杂环类化合物及其制备方法和用途 | |
| JPH02191300A (ja) | 抗体―薬物抱合体 | |
| WO2024235134A9 (zh) | 具有靶向作用的偶联物及其制备方法和用途 | |
| WO2024235130A1 (zh) | 多环化合物及其制备方法和用途 | |
| WO2024235133A9 (zh) | 多环类药物偶联物及其制备方法和用途 | |
| WO2024235135A1 (zh) | 大环化合物及其制备方法和用途 | |
| JP2026508115A (ja) | リンカー薬物、その抗体-薬物コンジュゲート、並びにそれらの調製方法及び使用 | |
| JP2025514436A (ja) | 親水性糖構造を含むリガンド薬物複合体 | |
| JP7753523B2 (ja) | Sn38を含む抗体-薬物コンジュゲートの中間体及びその調製方法 | |
| CN118767158A (zh) | 一种抗体-药物偶联物及其制备方法和用途 | |
| AU2024208501A1 (en) | Ligand-drug conjugates | |
| JP2025507707A (ja) | 新規の抗体薬剤コンジュゲート | |
| WO2025232688A1 (zh) | 并环类药物偶联物及其制备方法和用途 | |
| JP2025513664A5 (cg-RX-API-DMAC10.html) | ||
| WO2024235131A1 (zh) | 大环类药物偶联物及其制备方法和用途 | |
| JP2025532285A (ja) | 高安定性親水性リンカーユニットを有するアウリスタチン系薬物及びその複合体 | |
| HK40104908A (en) | Antibody-drug conjugate including antibody against human cldn18.2, and use thereof |